RPRX
Royalty Pharma plc · Healthcare
EVP, Research, Investments Marshall Urist sold $770K of Royalty Pharma plc
Sold$769,650
$38.48Price
20,000Shares
−16%Stake
What RPRX did after the filing
- The stock from Wed, Jan 7 open, $40.25
- +11.6%
- S&P 500, same days
- −0.4%
Measured over 30 trading days, to the Feb 20 close.
Traded Fri, Jan 2. Filed Tue, Jan 6, 4:17 PM ET, after the close. Returns use the Jan 7 open and the Feb 20 close. Not investment advice.